Database III: Genetic tests in development
Database of genetic tests in development
Table III-2: Test (by other types
of cancer)
Return to Contents
| Name |
Other Cancer |
Developer |
Data Source |
| AFP-L3 |
|
Wako |
LexisNexis |
| Alpha Catenin |
|
|
EDRN |
| APC |
|
|
EDRN |
| BAT-26 |
|
|
EDRN |
| Bladder cancer test |
Bladder |
ChondroGene, MSKCC |
LexisNexis |
| BladderChek |
Bladder |
M.D. Anderson C.C, Matritech Inc. |
LexisNexis |
| Breast Cancer Detection |
|
IMI International |
CHI |
| Breast Cancer Outcome Prediction Test |
|
Epigenomics, Roche Diagnostics |
LexisNexis |
| Cancer antigen 72-4 |
Stomach |
Roche Diagnostics |
Roche Diagnostics |
| CDK family |
|
M.D. Anderson |
LexisNexis |
| CDKN24 |
|
|
EDRN |
| CDP/Cux |
|
DiagnoCure, McGill U. |
LexisNexis |
| CellSearch |
|
Immunicon, Veridex. Quest Diagnostics |
LexisNexis, CHI |
| CeMines CellCorrect Lab |
|
CeMines |
LexisNexis |
| Chromosome 8q gain |
|
|
ClinicalTrials.gov |
| c-Kit pharmDx |
GIST |
DakoCytomation |
LexisNexis |
| Colorectal cancer test |
|
Microprevention Tests |
LexisNexis |
| Colorectal gene panel |
|
Quest diagnostics |
LexisNexis |
| Colorectalert |
|
IMI Medical |
LexisNexis, CHI |
| Conversion Analysis |
|
GMP Companies, Cleveland Clinic |
LexisNexis |
| Cox-2 RNA |
|
|
EDRN |
| cPSA |
|
|
FDA |
| CupPrint |
Tumor of unknown origin |
Agendia |
LexisNexis |
| Cyfra 21-1 |
|
Roche Diagnostics |
Roche Diagnostics |
| Cytokeratin 20 |
|
Roche Diagnostics |
Roche Diagnostics |
| CytoVision |
|
Applied Imaging Corp |
LexisNexis |
| des-gamma carboxyprothrombin |
|
|
EDRN |
| DNA methylation |
Kidney |
|
Google news, CHI |
| DNA methylation |
|
Orion Genomics, Methexis, Roche, Sequenom |
LexisNexis, CHI |
| EEF1A2 |
|
|
CISTI |
| EGFR |
Cervical, endometrial |
|
EDRN, ClinicalTrials.gov, CHI |
| EGFR |
|
Genzyme, DFCI, MGH |
LexisNexis |
| EPCA |
|
Tessera, Johns Hopkins U |
LexisNexis |
| eTag |
|
ViroLogic, AstraZeneca |
LexisNexis, CHI |
| Genomic Test |
|
|
ClinicalTrials.gov |
| GOS |
|
|
EDRN |
| GSTM1 |
|
|
Google news |
| GSTP1 |
|
|
EDRN, Google news |
| Her-1, Her-2, Her-3, Her-4 |
|
Roche Diagnostics |
Roche Diagnostics |
| HLA-E |
Gliomas |
|
Google news |
| HP1alpha |
|
|
CISTI |
| HPV test |
Cervical |
Diagene, GenoID |
LexisNexis |
| HPV test |
Cervical |
Roche Diagnostics |
Roche Diagnostics |
| IGF-II |
Cervical, endometrial |
|
EDRN |
| IMI breast cancer test |
|
IMI Medical |
LexisNexis |
| Immunocyt/ uCyt |
Bladder |
DiagnoCure, Gen-Probe |
LexisNexis |
| Iressa test |
|
U of Tokyo, AstraZeneca |
LexisNexis |
| Key2 |
|
Exagen |
LexisNexis |
| K-ras |
|
|
EDRN |
| Leukemia Affymetrix Chip |
|
Roche Diagnostics |
Roche Diagnostics |
| Leukemia blood test |
|
Genzyme |
CHI |
| Lung cancer test |
|
Cangen Biotech, Olympus |
LexisNexis |
| Lung cancer test |
|
Cleveland Clinic |
LexisNexis |
| LungAlert |
|
IMI Medical |
LexisNexis |
| Lysophopholipids |
|
|
ClinicalTrials.gov |
| M2-PK |
|
Giessen U |
LexisNexis |
| MammaPrint |
|
Agendia, Transbig, Molecular Profiling Institute |
LexisNexis |
| Matrix metalloproeinases |
|
|
ClinicalTrials.gov |
| Melanoma inhibiting antigen |
Melanoma |
Roche Diagnostics |
Roche Diagnostics |
| Melastatin |
Melanoma |
|
ClinicalTrials.gov |
| MESOMARK |
Mesothelioma |
Fujirebio Diagnostics |
LexisNexis |
| MGMT |
|
|
EDRN |
| Microsatelitte Analysis |
Bladder |
|
ClinicalTrials.gov |
| MLH1 |
|
|
EDRN |
| MN protein |
|
|
ClinicalTrials.gov |
| MSA |
Bladder |
|
EDRN, ClinicalTrials.gov |
| MSA analysis |
Bladder |
Cangen Biotech |
LexisNexis |
| NAF test |
|
Power3 |
LexisNexis |
| NMP179 |
Cervical |
Matritech Inc. |
LexisNexis |
| NMP22 |
Bladder |
|
FDA/ CHI |
| NMP35 |
|
Matritech Inc. |
LexisNexis |
| NMP48 |
|
Matritech Inc. |
LexisNexis |
| NMP66 |
|
Matritech Inc. |
LexisNexis, CHI |
| OncoVue breast cancer risk test |
|
Tm Bioscience/ Intergenetics |
LexisNexis, CHI |
| Ovacheck |
|
Quest, LabCorp, Correlogic |
LexisNexis |
| Ovarian cancer biomarker test |
|
Ciphergen Biosystems, Johns Hopkins |
LexisNexis |
| Ovarian cancer test |
|
Yale U |
LexisNexis |
| Ovarian cancer test |
|
Beth Israel Deaconess Medical Center |
LexisNexis |
| Ovarian pap test |
|
|
ClinicalTrials.gov |
| p16, p15, p14 deletions |
All |
|
ClinicalTrials.gov |
| p202 |
|
|
CISTI |
| p53 Affymetrix Chip |
Others |
Roche Diagnostics |
Roche Diagnostics |
| Prostate 63 |
|
|
CLIA |
| Prostate biomarkers |
|
Health Discovery Corporation/Stanford U |
CHI |
| Prostate Cancer Blood Test |
|
Correlogic |
CHI |
| Protein Profile test |
|
|
ClinicalTrials.gov |
| PSA testing |
|
Qualigen, Healthtronics |
LexisNexis |
| PSMA |
|
Cytogen |
CHI |
| PSP94 |
|
Procyon, Medicorp |
LexisNexis |
| PTEN tumor suppressor |
|
|
CISTI |
| PyloriProbe |
|
AMDL |
LexisNexis |
| Recaf |
|
Abbot, BioCurex |
LexisNexis |
| RhoC GTPase |
|
|
CISTI |
| S100 |
Melanoma |
Roche Diagnostics |
Roche Diagnostics |
| SELDI-TOF-MS |
|
|
EDRN |
| SurePath |
Cervical |
Tripath Imaging |
LexisNexis |
| Telomerase |
Bladder |
Roche Diagnostics |
Roche Diagnostics |
| TGF genes |
|
|
Google news |
| TUO test |
Tumor of unknown origin |
US LABS |
LexisNexis |
| uPM3 |
|
DiagnoCure, Gen-Probe |
LexisNexis |
| Urinary plasminogen activator |
|
|
ClinicalTrials.gov |
| Urine test for cervical cancer |
Cervical |
U. Washington |
LexisNexis |
| VEGF |
|
Quest |
LexisNexis |
| WISP3 |
|
|
CISTI |
Return to Contents
Proceed to Next Section
|
540 Gaither Road Rockville, MD 20850